Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials.
Nutr Metab Cardiovasc Dis
; 31(10): 2745-2755, 2021 09 22.
Article
in En
| MEDLINE
| ID: mdl-34364771
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adamantane
/
Cardiovascular Diseases
/
Diabetes Mellitus, Type 2
/
Dipeptides
/
Dipeptidyl-Peptidase IV Inhibitors
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Nutr Metab Cardiovasc Dis
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
CIENCIAS DA NUTRICAO
/
METABOLISMO
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: